⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30303131 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL29141671 | 0.77 | MAOB (0.31) | — | |
| SCHEMBL15336897 | 0.73 | — | — | |
| SCHEMBL79182 | 0.72 | — | — | |
| SCHEMBL12501184 | 0.72 | — | — | |
| SCHEMBL4742935 | 0.72 | CA2 (0.37) | — | |
| SCHEMBL31159539 | 0.71 | HDAC1 (0.50) | — | |
| SCHEMBL9244287 | 0.69 | TPMT (0.41) | — | |
| SCHEMBL2023689 | 0.69 | — | — | |
| SCHEMBL1512247 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090017015-A1 | Dpp-iv inhibitors for treating neurodegeneration and cognitive disorders | HUGHES THOMAS EDWARD | 2009-01-15 | — | — | US | claimed |
| US-20070110715-A1 | Treatment of alzheimer's disease | ARES TRADING S.A. (CH) | 2007-05-17 | — | — | US | claimed |
| EP-1732550-A2 | DPP-IV INHIBITORS FOR TREATING NEURODEGENERATION AND COGNITIVE DISORDERS | Novartis AG (CH) | 2006-12-20 | — | — | EP | claimed |
| EP-1620124-A2 | IFN-BETA ALONE OR IN COMBINATION WITH OTHER MEDICAMENTS FOR TREATING ALZHEIMER'S DISEASE AND DEMENS DISORDERS | ARES TRADING S.A. (CH) | 2006-02-01 | — | — | EP | claimed |
| WO-2005079795-A2 | DPP-IV INHIBITORS FOR TREATING NEURODEGENERATION AND COGNITIVE DISORDERS | NOVARTIS AG (CH) | 2005-09-01 | — | — | WO | claimed |
| WO-2004082706-A2 | IFN-BETA ALONE OR IN COMBINATION WITH OTHER MEDICAMENTS FOR TREATING ALZHEIMER'S DISEASE AND DEMENS DISORDERS | ARES TRADING S.A. (CH) | 2004-09-30 | — | — | WO | claimed |
| WO-2021002735-A1 | CELL SURFACE ANTIGEN OF T CELL AND VARIOUS USES THEREOF | 주식회사 굳티셀 | 2021-01-07 | — | — | WO | disclosed |
| US-20100160408-A1 | VILDAGLIPTIN FOR TREATING GENERAL PERIPHERAL NEUROPATHIES | NOVARTIS AG (CH) | 2010-06-24 | — | — | US | disclosed |
| US-20090017015-A1 | Dpp-iv inhibitors for treating neurodegeneration and cognitive disorders | HUGHES THOMAS EDWARD | 2009-01-15 | — | — | US | disclosed |
| US-20070110715-A1 | Treatment of alzheimer's disease | ARES TRADING S.A. (CH) | 2007-05-17 | — | — | US | disclosed |
| EP-1732550-A2 | DPP-IV INHIBITORS FOR TREATING NEURODEGENERATION AND COGNITIVE DISORDERS | Novartis AG (CH) | 2006-12-20 | — | — | EP | disclosed |
| EP-1620124-A2 | IFN-BETA ALONE OR IN COMBINATION WITH OTHER MEDICAMENTS FOR TREATING ALZHEIMER'S DISEASE AND DEMENS DISORDERS | ARES TRADING S.A. (CH) | 2006-02-01 | — | — | EP | disclosed |
| WO-2005079795-A2 | DPP-IV INHIBITORS FOR TREATING NEURODEGENERATION AND COGNITIVE DISORDERS | NOVARTIS AG (CH) | 2005-09-01 | — | — | WO | disclosed |
| US-5488054-A | TREATMENT OF RESTENOSIS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-01-30 | — | — | US | disclosed |
| US-5486522-A | Carbamates of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-01-23 | — | — | US | disclosed |
| US-5486524-A | RESTENOSIS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-01-23 | — | — | US | disclosed |
| US-5486523-A | ANTIINFLAMMATORY | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-01-23 | — | — | US | disclosed |
| US-5484791-A | TREATING PULMONARY INFLAMMATION | AMERICAN HOME PRODUCTS CORPORATION | 1996-01-16 | — | — | US | disclosed |
| US-5484790-A | IMMUNOSUPPRESSANT IN TRANSPLANTS OR GRAFTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-01-16 | — | — | US | disclosed |
| US-5480988-A | USEFUL AS AN IMMUNOSUPPRESSANT, ANTIINFLAMMATORY AGENT, FUNGICIDE, ANTIGROWTH AGENT OR ANTITUMOR AGENT | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-01-02 | — | — | US | disclosed |